Highly precise radiopharmaceuticals can be used to effectively diagnose or treat tumors expressing specific receptors on their surface. Watch the video to learn more about their mode of action (MoA).

Watch experts discussing the topic of 'Developments in Theranostics and Neuroendocrine Tumors.' The event took place during the ENETS 2023 in Vienna.

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.